Can add this to the list, TS.

when the ceo doesn't even wanna take it, you know something is fishy.

Good luck to those guinea pigs 

The vaccine was just 50.4% effective at preventing symptomatic infections in the Brazilian trial, including data on “very mild” cases, researchers said on Tuesday.

Last week, they said the vaccine, called CoronaVac, showed 78% efficacy against “mild-to-severe” cases.

The news prompted Malaysia and Singapore, which have purchase agreements with Sinovac, to say on Wednesday that they would seek more data from the Chinese firm on efficacy rates before they approved and bought supplies.

“These Phase III clinical trial results are sufficient to prove that CoronaVac vaccine’s safety and effectiveness are good around the world,” Sinovac Biotech Chairman Yin Weidong told a news conference.

Different countries used vaccines from the same batch in their trials, but the countries don’t have identical testing protocols, he said.

Piecemeal disclosures from Sinovac’s trials as well as those from studies of other Chinese vaccines have raised concerns that they are not subject to the same public scrutiny as U.S. and European alternatives.

The Brazilian results suggest CoronaVac is far less effective than vaccines developed by Pfizer-BioNTech and Moderna, which have an efficacy rate of about 95%. Russia says its Sputnik V vaccine has an efficacy of 91%, while the UK's vaccine, developed by Oxford University and AstraZeneca, has an average efficacy of 70%. The Sinovac vaccine has a lower efficacy rate than its domestic Chinese competitor, developed by the state-owned Sinopharm, which it says has a 79.34% efficacy.

when the ceo doesn't even wanna take it, you know something is fishy.

it gets better
https://edition.cnn.com/2021/01/17/asia/sin...-hnk/index.html
https://www.reuters.com/article/health-coro...a-idINKBN29I13L
that said the pfizer vaccine isn't going to be practical for people not living in urban areas.

it gets better
https://edition.cnn.com/2021/01/17/asia/sin...-hnk/index.html
https://www.reuters.com/article/health-coro...a-idINKBN29I13L
that said the pfizer vaccine isn't going to be practical for people not living in urban areas.

Already knew gonna happen because of piece meal approach with with different standards in place with the kinda of approach they are using

Just like Turkey claims of 91.25% efficiency act when the sample pool was of only for 3000 participants 

Originally designed to take the second dose after 4 weeks, but instead the participants were given the second dose after only 2 weeks.

But nearly 1,400 of them took the vaccine 1 week late at 3 weeks, and their efficacy level of this group went up by 20% to 70%.

https://www.bloomberg.com/news/articles/202...-confusing-data

Somebody probably had screwed-up, thinking there was no difference in efficacy if the interval was shortened.

In the UK, the interval between Pfizer jabs have been widened to 12 weeks.

Yes, it is perfectly safe.

Anyone who says otherwise will be banned off FB, Twitter and other platforms.

Posted from Zuckerberg approved account.